Back to market news

EU drug agency approved Moderna’s vaccine

EU drug agency approved Moderna’s vaccine

EU drug agency approved Moderna’s vaccine

The European Medicines Agency (EMA) has recommended Moderna as the second vaccine against COVID-19 for conditional authorization in the European Union today. For EU countries to start using a substance from an American company after the Pfizer and BioNTech vaccine, its distribution has yet to be approved by the European Commission. 

Emer Cooke, the agency's head of conditional recommendations commented: "This vaccine gives us another tool to overcome the current crisis." According to her, the EMA will continue to monitor the safety and efficacy data provided by the manufacturer. The agency recommended that the vaccine be given to patients over 18 years of age.

The EU announced that it will exercise the option for 100 million additional doses of vaccine from the Pfizer-BioNTech. It is also negotiating an agreement that could double that number, people familiar with the talks said on Tuesday.

Moderna shares are up by more than 3% before the opening of US stock exchanges.

Performance of Moderna’s shares (Tradingview.com)

Read more

Nike Q4 earnings and revenue beat estimates

Nike Q4 earnings and revenue beat estimates

The sneaker giant Nike (NYSE: NKE) delivered better-than-expected financial results for the fourth quarter on Monday after market close. “Nike’s results this fiscal year are a testament to the unmatched strength of our brands and our deep connection with consumers," Nike CEO, John Donahoe said.

Weekly review: Gold, USD, EURUSD and Dow Jones

Weekly review: Gold, USD, EURUSD and Dow Jones

Major stock markets around the world started the week on a positive note. However, many market participants continue to digest the shift of focus away from inflation and back to the economic slowdown. However, this will be an exciting week as the European Central Bank will host a forum in Portugal.